Supply Chain

A new study shows supply chain executives demonstrate higher levels of psychopathic tendencies than any other role in the business world, reports the AustralianFinancial Review.

Lake Forest, Ill.-based Horizon Pharma will reportedly buy La Jolla, Calif.-based Raptor Pharmaceutical for $800 million, according to Reuters.

Veniti, the developer of a patented venous stent system, has secured $25 million in funding from Boston Scientific Corp. The company will use the investment to complete a trial and regulatory filing for its stent system as well as grow…

San Diego-based Obalon Therapeutics earned Food and Drug Administration approval for its Obalon Balloon System, a nonsurgical weight loss device for patients who failed to lose weight through diet and exercise.

GlaxoSmithKline will sell its anesthetic drug business to South Africa-based Aspen Pharmacare for up to $372 million.

Israel-based Teva Pharmaceuticals seeks to earn Food and Drug Administration approval for its generic version of Mylan's EpiPen by late 2017 or early 2018.

The Food and Drug Administration recently approved India-based Glenmark Pharmaceutical's lidocaine ointment.

The high price of EpiPens introduced a nationwide discussion on Mylan's pricing practices and the overall state of the drug industry. However, not all parts of the discussion have been accurate.

Procured Health recently hosted a panel to discuss effective physician engagement strategies to produce a more efficient supply chain that improves costs, quality and clinical outcomes.

While numerous companies attempted to set foot in the epinephrine auto-injection market, none were able to significantly impact Canonsburg, Pa.-based Mylan's control of the market. This dominance allowed Mylan to make major price hikes to its EpiPens, increasing the price by…